Neumora Therapeutics (NMRA) Stock Price & Financial Analysis
Neumora Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Neumora Therapeutics
What is the current stock price for NMRA?
As of the latest trading session, NMRA stock trades at $1.51. The 52-week range is $0.72–$3.65, with a day range of $1.43–$1.63.
What is the P/E ratio for NMRA?
The P/E ratio (Price-to-Earnings) for NMRA is shown in the Key Statistics section. This valuation metric helps compare Neumora Therapeutics, Inc. to industry peers.
Does NMRA pay dividends?
Neumora Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NMRA?
Based on 8 analysts, the consensus for NMRA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of NMRA?
Neumora Therapeutics's market capitalization is $271.6M, classifying it as a micro-cap company. Neumora Therapeutics operates in the Healthcare sector within the Biotechnology industry.